FibroGen Sells Chinese Subsidiary to AstraZeneca for $160 Million
Deal News | Mar 06, 2025 | Ropes & Gray
FibroGen, Inc., a biopharmaceutical company specializing in cancer biology and anemia therapies, has sold its China subsidiary, Fibrogen China, to AstraZeneca for around $160 million. Ropes & Gray, a renowned law firm, advised FibroGen on this significant transaction. The announcement of the deal was made public in a press release on February 20. The advisory team from Ropes & Gray consisted of several distinguished partners and an associate, covering various specialties including mergers & acquisitions, litigation, tax, private equity, intellectual property, executive compensation, and life sciences.
Sectors
- Biopharmaceutical
- Legal Services
- Mergers and Acquisitions
Geography
- China – The subsidiary being sold, Fibrogen China, is based in China.
- United States – FibroGen, Inc., the parent company, is based in the United States.
- United Kingdom – AstraZeneca, the acquiring company, is headquartered in the United Kingdom.
Industry
- Biopharmaceutical – The article discusses FibroGen, a company in the biopharmaceutical industry involved in developing therapies for cancer and anemia.
- Legal Services – Ropes & Gray, a law firm, provided legal advisory services for the transaction.
- Mergers and Acquisitions – The article covers a transaction involving the sale of Fibrogen China to AstraZeneca, indicative of M&A activities.
Financials
- 160000000 – Sale price of Fibrogen China to AstraZeneca.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| FibroGen, Inc. | Seller | Company | A biopharmaceutical company focused on cancer biology and anemia therapies. |
| Fibrogen China | Target | Company | The Chinese subsidiary of FibroGen that was sold to AstraZeneca. |
| AstraZeneca | Buyer | Company | A global pharmaceutical company acquiring Fibrogen China. |
| Ropes & Gray | Legal Advisor | Company | A law firm that advised FibroGen on the sale. |
| Arthur Mok | Mergers & Acquisitions Partner | Person | Led the Ropes & Gray team advising on the transaction. |
| Reed Harasimowicz | Associate | Person | Part of the Ropes & Gray advisory team. |
| Lisa Kaltenbrunner | Litigation & Enforcement Partner | Person | Involved in the Ropes & Gray team for the transaction. |
| Benjamin Rogers | Tax Partner | Person | Part of the Ropes & Gray advisory team. |
| Oliver Nip | Private Equity Partner | Person | Involved in the Ropes & Gray team for the transaction. |
| Geoffrey Lin | IP Transactions Partner | Person | Part of the Ropes & Gray advisory team. |
| Ellen Sueda | Executive Compensation & Employee Benefits Partner | Person | Part of the Ropes & Gray advisory team. |
| Katherine Wang | Life Sciences Partner | Person | Part of the Ropes & Gray advisory team. |